Stocks
Allogene Therapeutics (ALLO) P/FCF US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -14.0 | -16.8 | -9.82 | -3.99 | -2.11 | -2.85 | |||
| Changes by years, y/y, % | -14% | +20% | -41% | -59% | -47% | -33.6% | |||
Allogene Therapeutics. P/FCF
Allogene Therapeutics. P/FCF, changes, %
Allogene Therapeutics (ALLO) P/FCF US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/FCF | -2.13 | -2.26 | -3.32 | -1.93 | -2.69 | -2.85 | ||
| Changes by years, y/y, % | -71% | -44% | +4% | -36% | +26% | |||
| Changes by quarters, q/q, % | -29% | +6% | +47% | -42% | +39% | |||
